|
1
|
Ohtani H, Tamamori Y, Arimoto Y,
Nishiguchi Y, Maeda K and Hirakawa K: A meta-analysis of the short-
and long-term results of randomized controlled trials that compared
laparoscopy-assisted and conventional open surgery for colorectal
cancer. J Cancer. 2:425–434. 2011. View Article : Google Scholar
|
|
2
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′ UTR as in the 3′ UTR. Proc Natl Acad Sci USA. 104:9667–9672.
2007.PubMed/NCBI
|
|
4
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamashita S, Yamamoto H, Mimori K, et al:
MicroRNA-372 is associated with poor prognosis in colorectal
cancer. Oncology. 82:205–212. 2012.PubMed/NCBI
|
|
6
|
Rossi S, Di Narzo AF, Mestdagh P, et al:
microRNAs in colon cancer: a roadmap for discovery. FEBS Lett.
586:3000–3007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rawson JB and Bapat B: Epigenetic
biomarkers in colorectal cancer diagnostics. Expert Rev Mol Diagn.
12:499–509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahmed FE, Amed NC, Vos PW, et al:
Diagnostic microRNA markers to screen for sporadic human colon
cancer in blood. Cancer Genomics Proteomics. 9:179–192.
2012.PubMed/NCBI
|
|
9
|
Wang Y, Lee AT, Ma JZ, et al: Profiling
microRNA expression in hepatocellular carcinoma reveals
microRNA-224 up-regulation and apoptosis inhibitor-5 as a
microRNA-224-specific target. J Biol Chem. 283:13205–13215. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Toh HC, Chow P, et al:
MicroRNA-224 is up-regulated in hepatocellular carcinoma through
epigenetic mechanisms. FASEB J. 26:3032–3041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang L, Dai T, Lin X, et al: MicroRNA-224
targets RKIP to control cell invasion and expression of metastasis
genes in human breast cancer cells. Biochem Biophys Res Commun.
425:127–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mees ST, Mardin WA, Sielker S, et al:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Takahashi S, Tasaka A, Yoshima T,
Ochi H and Chayama K: Involvement of microRNA-224 in cell
proliferation, migration, invasion and anti-apoptosis in
hepatocellular carcinoma. J Gastroenterol Hepatol. 28:565–575.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yao G, Yin M, Lian J, et al: MicroRNA-224
is involved in transforming growth factor-beta-mediated mouse
granulosa cell proliferation and granulosa cell function by
targeting Smad4. Mol Endocrinol. 24:540–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rossi L, Bonmassar E and Faraoni I:
Modification of miR gene expression pattern in human colon cancer
cells following exposure to 5-fluorouracil in vitro. Pharmacol Res.
56:248–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mencia N, Selga E, Noe V and Ciudad CJ:
Underexpression of miR-224 in methotrexate resistant human colon
cancer cells. Biochem Pharmacol. 82:1572–1582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu J, Tang W, Du P, et al: Identifying
microRNA-mRNA regulatory network in colorectal cancer by a
combination of expression profile and bioinformatics analysis. BMC
Syst Biol. 6:682012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scisciani C, Vossio S, Guerrieri F, et al:
Transcriptional regulation of miR-224 upregulated in human HCCs by
NFκB inflammatory pathways. J Hepatol. 56:855–861. 2012.PubMed/NCBI
|
|
20
|
Wotschofsky Z, Busch J, Jung M, et al:
Diagnostic and prognostic potential of differentially expressed
miRNAs between metastatic and non-metastatic renal cell carcinoma
at the time of nephrectomy. Clin Chim Acta. 416:5–10. 2013.
View Article : Google Scholar
|
|
21
|
Liu ZR, Chen XW, Qiao XH, Wang R and Xiang
Z: Detection of miR-122a and miR-224 expression in hepatocellular
carcinoma by real-time fluorescence quantitative RT-PCR. Nan Fang
Yi Ke Da Xue Xue Bao. 29:751–753. 2009.(In Chinese).
|
|
22
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poma P, Labbozzetta M, Vivona N, Porcasi
R, D’Alessandro N and Notarbartolo M: Analysis of possible
mechanisms accounting for raf-1 kinase inhibitor protein
downregulation in hepatocellular carcinoma. OMICS. 16:579–588.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu L, Li H, Jia CY, et al: MicroRNA-223
regulates FOXO1 expression and cell proliferation. FEBS Lett.
586:1038–1043. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Xiao Z, Lai D, et al: miR-21,
miR-17 and miR-19a induced by phosphatase of regenerating liver-3
promote the proliferation and metastasis of colon cancer. Br J
Cancer. 107:352–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Q, Liu LZ, Qian X, et al: MiR-145
directly targets p70S6K1 in cancer cells to inhibit tumor growth
and angiogenesis. Nucleic Acids Res. 40:761–774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nigg EA: Cyclin-dependent protein kinases:
key regulators of the eukaryotic cell cycle. Bioessays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zucca E and Nigg EA: Cell cycle regulation
and the function of cancer genes. Ann Oncol. 6:975–978.
1995.PubMed/NCBI
|
|
29
|
Wang L, Cao XX, Chen Q, Zhu TF, Zhu HG and
Zheng L: DIXDC1 targets p21 and cyclin D1 via PI3K pathway
activation to promote colon cancer cell proliferation. Cancer Sci.
100:1801–1808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mitomi H, Ohkura Y, Fukui N, et al:
P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras
mutations and prognosis. Eur J Gastroenterol Hepatol. 19:883–889.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim JA, Park KS, Kim HI, et al:
Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15
human colorectal cancer cells. Cancer Lett. 179:185–195. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pasz-Walczak G and Kordek R: Comparative
evaluation of the expression of cell cycle regulating proteins:
cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pol J Pathol.
51:63–69. 2000.PubMed/NCBI
|
|
33
|
Pasz-Walczak G, Kordek R and Faflik M: P21
(WAF1) expression in colorectal cancer: correlation with P53 and
cyclin D1 expression, clinicopathological parameters and prognosis.
Pathol Res Pract. 197:683–689. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Noske A, Lipka S, Budczies J, et al:
Combination of p53 expression and p21 loss has an independent
prognostic impact on sporadic colorectal cancer. Oncol Rep. 22:3–9.
2009.PubMed/NCBI
|
|
35
|
Park KS, Ahn Y, Kim JA, Yun MS, Seong BL
and Choi KY: Extracellular zinc stimulates ERK-dependent activation
of p21Cip/WAF1 and inhibits proliferation of colorectal
cancer cells. Br J Pharmacol. 137:597–607. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Al-Maghrabi J, Al-Ahwal M, Buhmeida A, et
al: Expression of cell cycle regulators p21 and p27 as predictors
of disease outcome in colorectal carcinoma. J Gastrointest Cancer.
43:279–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
